Doz

Frovatriptan

فرواتریپتان

⚠ Unverified

🧠 Nervous SystemTriptan (5-HT1B/1D agonist)

🤰 Pregnancy:Use with caution🤱 Breastfeeding:Use with caution👶 Children:Safety not established👴 Older adults:No specific problem stated 🇮🇷 Not found in Iran list⛔ 1 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA216998ATC N02CC07

Market / country: 🇺🇸 USA

Frova (US)

🧮 Dose calculator

Acute migraine attack · Regimen source: FDA Frovatriptan · 2

  • • If it recurs after initial relief: second dose at least 2 h later; max 3 tablets (7.5 mg) in 24 h. FDA Frovatriptan · 2

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

  • ⛔ Ischaemic coronary disease or coronary vasospasm (Prinzmetal); WPW or accessory-pathway arrhythmias; history of stroke, TIA or hemiplegic/basilar migraine; peripheral vascular disease; ischaemic bowel disease; uncontrolled hypertension; another triptan or ergot within 24 h; hypersensitivity. FDA Frovatriptan · 4

Warnings

  • • Myocardial ischaemia and infarction; arrhythmias; chest/throat/jaw tightness; cerebrovascular events; medication-overuse headache; serotonin syndrome; increased blood pressure. FDA Frovatriptan · 5

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Frovatriptan · 8.1

    “Risk Summary There are no adequate data on the developmental risk associated with the use of frovatriptan succinate in pregnant women.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Frovatriptan · 8.2

    “Risk Summary There are no data on the presence of frovatriptan in human milk, the effects of frovatriptan on the breastfed infant, or the effects of frovatriptan on milk production.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Frovatriptan · 8.4

    “The safety and effectiveness in pediatric patients have not been established.”
  • 👴 Older adultsNo specific problem stated

    Label: no specific difference or dose adjustment stated for older adults. FDA Frovatriptan · 8.5

    “No dosage adjustment is necessary.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav